Drug Discovery Informatics Market
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Drug Discovery Informatics Market Through 2025?
The emergence and rapid expansion of the drug discovery informatics market have been significant in recent years. Projected to increase from $3.69 billion in 2024 to $4.09 billion in 2025, it exhibits a compound annual growth rate (CAGR) of 11.1%. The historic period’s growth stems from progressive enhancements in genomics and proteomics, the increasing intricacy of drug targets, advancements in structural biology, an uptick in outsourcing, the incorporation of pharmacogenomics, and strategies for drug repurposing.
What’s the Projected Size of the Global Drug Discovery Informatics Market by 2029?
In the coming years, it is anticipated that the drug discovery informatics market will experience significant expansion. It is predicted to reach $6.98 billion in size by the year 2029, growing at a compound annual growth rate (CAGR) of 14.3%. This projected development is largely due to factors such as the broadening of precision medicine, the prediction of drug-drug interactions, analysis of patient-derived data, biosimilars development, and an increasing amount of drug candidates. Some of the key trends expected to influence this sector during the forecast period include the integration of AI and machine learning, the use of digital twins in drug development, collaborative platforms, blockchain for improved data security, advancements in imaging technologies, and the use of cloud-based informatics platforms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report
Top Growth Drivers in the Drug Discovery Informatics Industry: What’s Accelerating the Market?
The escalating incidence of multiple chronic diseases is predicted to fuel the expansion of the drug discovery informatics market in the future. Chronic diseases are generally identified as conditions that last for over a year and require ongoing medical attention or interfere with daily activities, or both. Drug discovery informatics mechanisms support the progression of chronic disease management by enabling scientists to investigate intricate and fleeting molecular alterations that drive disease development and medicinal response, leading to multi-dimensional designs of the whole hierarchical system in healthy, diseased, and medicated states. For example, a 2022 report published by the World Health Organization, a Switzerland-based United Nations agency committed to global health, forecasts that non-communicable diseases (NCDs) will cause 41 million deaths, constituting 74% of all deaths globally. Every year, 17 million individuals succumb to an NCD before turning 70, with 86% of these premature deaths occurring in low- and middle-income countries. With 17.9 million deaths annually, cardiovascular diseases are the deadliest, followed by cancer (9.3 million), chronic respiratory ailments (4.1 million), and diabetes (2.0 million, including deaths from kidney disease caused by diabetes). Hence, the ongoing rise in the incidence of various chronic diseases is stimulating the expansion of the drug discovery informatics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8960&type=smp
What Trends Will Shape the Drug Discovery Informatics Market Through 2029 and Beyond?
The advancement of technology is a significant trend gaining traction in the drug discovery informatics market. Prominent companies in this market are striving to develop technologically sophisticated solutions in order to consolidate and expand their market standing. For example, Illumina Inc., a biotechnology company from the US, introduced a new cloud-based software called Connected Insights in March 2023 that allows tertiary analysis for clinical next-generation sequencing (NGS) data. The design of Connected Insights facilitates interpretation and reporting from an assortment of assay types, allowing labs to significantly enhance the use of NGS and decrease the time taken for clinical reporting through integration with third-party knowledge bases. Moreover, it is intended to support a broad array of applications, including whole-genome sequencing (WGS) for rare diseases in the near future. The Illumina Connected Software is a comprehensive software ecosystem that standardizes analysis tools and amalgamates data across the genomics workflow. By interfacing with Illumina sequencers and providing access to DRAGEN secondary analysis, the Illumina Connected Software presents an effective, accurate, flexible analysis setting ready to be scaled as per each customer’s workflow.
What Are the Main Segments in the Drug Discovery Informatics Market?
The drug discovery informatics market covered in this report is segmented –
1) By Service: In-House, Outsourced
2) By Modality: Cloud-Based Systems, In-Campus
3) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies
Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling, Other In-House Services
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services, Other Outsourced Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8960&type=smp
Which Top Companies are Driving Growth in the Drug Discovery Informatics Market?
Major companies operating in the drug discovery informatics market include accenture* Plc., Certara Inc., Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products Inc., Jubilant Biosys Ltd., Selvita S.A., PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., ChemAxon Ltd., Amazon Web Services Inc., Schrödinger LLC., Core Informatics LLC, Informatics Matters Ltd., Tata Consultancy Services Limited, Novo Informatics Pvt. Ltd., IO Informatics Inc., GVK Biosciences Private Limited, Dassault Systèmes SE, Recursion Pharmaceuticals Inc., Cyclica Inc., Valence Discovery Inc., Valo Health Inc., Cognizant Technology Solutions Corporation, Wipro Limited, Mindtree Limited, Persistent Systems Limited, Mphasis Limited
Which Regions Will Dominate the Drug Discovery Informatics Market Through 2029?
North America was the largest region in the drug discover informatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8960
This Report Supports:
1. Business Leaders & Investors – To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers – To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators – To track industry developments and align regulatory frameworks.
4. Consultants & Analysts – To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
